Advertisement
UK markets close in 3 hours 16 minutes

  • FTSE 100

    8,097.31
    +56.93 (+0.71%)
     

  • FTSE 250

    19,729.60
    +10.23 (+0.05%)
     

  • AIM

    755.33
    +0.64 (+0.08%)
     

  • GBP/EUR

    1.1672
    +0.0027 (+0.23%)
     

  • GBP/USD

    1.2512
    +0.0049 (+0.39%)
     

  • Bitcoin GBP

    51,187.33
    -2,057.84 (-3.86%)
     

  • CMC Crypto 200

    1,358.09
    -24.48 (-1.77%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    83.09
    +0.28 (+0.34%)
     

  • GOLD FUTURES

    2,341.40
    +3.00 (+0.13%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,997.57
    -91.13 (-0.50%)
     

  • CAC 40

    8,031.18
    -60.68 (-0.75%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

AstraZeneca to pay $5.52 mln to resolve U.S. SEC foreign bribery case

Reuters - UK Focus

NEW YORK, Aug 30 (Reuters) - U.S (Other OTC: UBGXF - news) . regulators said on Tuesday that AstraZeneca Plc (NYSE: AZN - news) will pay $5.52 million to resolve a foreign bribery probe into improper payments by its sales and marketing staff to officials at state-controlled health care providers in China and Russia.

The U.S. Securities and Exchange Commission detailed the settlement with the drug company in an order instituting an administrative proceeding arising out of violations of provisions of the Foreign Corrupt Practices Act. (Reporting by Nate Raymond in New York; Editing by Alan Crosby)